Related references
Note: Only part of the references are listed.Suppression of galectin-4 attenuates peritoneal metastasis of poorly differentiated gastric cancer cells
Hiroko Ideo et al.
GASTRIC CANCER (2023)
Galectins as pivotal components in oncogenesis and immune exclusion in human malignancies
Nikiforos-Ioannis Kapetanakis et al.
FRONTIERS IN IMMUNOLOGY (2023)
Placental Galectins in Cancer: Why We Should Pay More Attention
Camille Fuselier et al.
CELLS (2023)
T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma
Chenguang Li et al.
JOURNAL OF NEURO-ONCOLOGY (2023)
Protein degraders enter the clinic - a new approach to cancer therapy
Deborah Chirnomas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2023)
Targeting galectin-driven regulatory circuits in cancer and fibrosis
Karina V. Marino et al.
NATURE REVIEWS DRUG DISCOVERY (2023)
mRNA-based cancer therapeutics
Chuang Liu et al.
NATURE REVIEWS CANCER (2023)
Galectin-8, cytokines, and the storm
Yehiel Zick
BIOCHEMICAL SOCIETY TRANSACTIONS (2022)
Sweet Immune Checkpoint Targets to Enhance T Cell Therapy
Nohelly Derosiers et al.
JOURNAL OF IMMUNOLOGY (2022)
Therapeutic potential of targeting galectins-A biomaterials-focused perspective
Sergio Martin-Saldana et al.
BIOMATERIALS (2022)
Combining Recombinase-Mediated Cassette Exchange Strategy with Quantitative Proteomic and Phosphoproteomic Analyses to Inspect Intracellular Functions of the Tumor Suppressor Galectin-4 in Colorectal Cancer Cells
Malwina Michalak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer
Peng Ji et al.
SCIENCE ADVANCES (2022)
Galectin-8 and-9 as prognostic factors for cervical cancer
Susanne Beyer et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2022)
Galectin-8 Is Upregulated in Keratinocytes by IL-17A and Promotes Proliferation by Regulating Mitosis in Psoriasis
Yuan-Hsin Lo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
Human galectin-16 has a pseudo ligand binding site and plays a role in regulating c-Rel-mediated lymphocyte activity
Yunlong Si et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2021)
Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment
Wenxi Zhou et al.
BIOMATERIALS (2021)
Discovery of novel cell-penetrating and tumor-targeting peptide-drug conjugate (PDC) for programmable delivery of paclitaxel and cancer treatment
Xin Deng et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Optimization of AAV vectors to target persistent viral reservoirs
Rossana Colon-Thillet et al.
VIROLOGY JOURNAL (2021)
Development of MDM2 degraders based on ligands derived from Ugi reactions: Lessons and discoveries
Bo Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Targeting galectins in T cell-based immunotherapy within tumor microenvironment
Qiu-Yang Jin et al.
LIFE SCIENCES (2021)
Peptide-tiling screens of cancer drivers reveal oncogenic protein domains and associated peptide inhibitors
Kyle M. Ford et al.
CELL SYSTEMS (2021)
Intracellular galectins sense cytosolically exposed glycans as danger and mediate cellular responses
Ming-Hsiang Hong et al.
JOURNAL OF BIOMEDICAL SCIENCE (2021)
Overexpression of Galectin10 Predicts a Better Prognosis in Human Ovarian Cancer
Wenxiao Jiang et al.
JOURNAL OF CANCER (2021)
Charcot-Leyden crystal protein/galectin-10 interacts with cationic ribonucleases and is required for eosinophil granulogenesis
Milica M. Grozdanovic et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery
Natalie F. Nidetz et al.
PHARMACOLOGY & THERAPEUTICS (2020)
High Galectin-7 and Low Galectin-8 Expression and the Combination of both are Negative Prognosticators for Breast Cancer Patients
Anna Trebo et al.
CANCERS (2020)
A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS
Nicolas Bery et al.
NATURE COMMUNICATIONS (2020)
Galectins control MTOR and AMPK in response to lysosomal damage to induce autophagy
Jingyue Jia et al.
AUTOPHAGY (2019)
Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies
Justine Habault et al.
MOLECULES (2019)
High-throughput identification of dominant negative polypeptides in yeast
Michael W. Dorrity et al.
NATURE METHODS (2019)
Protein crystallization promotes type 2 immunity and is reversible by antibody treatment
Emma K. Persson et al.
SCIENCE (2019)
The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma
Gregg B. Fields
CELLS (2019)
The ALFA-tag is a highly versatile tool for nanobody-based bioscience applications
Hansjoerg Goetzke et al.
NATURE COMMUNICATIONS (2019)
Stimulation of Collateral Vessel Growth by Inhibition of Galectin 2 in Mice Using a Single-Domain Llama-Derived Antibody
Maurits R. Hollander et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Extracellular and intracellular small-molecule galectin-3 inhibitors
John Stegmayr et al.
SCIENTIFIC REPORTS (2019)
O-Glycosylation-mediated signaling circuit drives metastatic castration-resistant prostate cancer
Sheue-Fen Tzeng et al.
FASEB JOURNAL (2018)
Galectins Control mTOR in Response to Endomembrane Damage
Jingyue Jia et al.
MOLECULAR CELL (2018)
Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk
Carlos A. Orozco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
HSP40 co-chaperone protein Tid1 suppresses metastasis of head and neck cancer by inhibiting Galectin-7-TCF3-MMP9 axis signaling
Yu-Syuan Chen et al.
THERANOSTICS (2018)
Targeted protein degradation by PROTACs
Taavi K. Neklesa et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Surface-bound galectin-4 regulates gene transcription and secretion of chemokines in human colorectal cancer cell lines
U. Subrahmanyeswara Rao et al.
TUMOR BIOLOGY (2017)
Inverse correlation between galectin-4 and TTF-1 in lung adenocarcinoma
Kieko Hara et al.
VIRCHOWS ARCHIV (2017)
Galectin-1 knockdown improves drug sensitivity of breast cancer by reducing P-glycoprotein expression through inhibiting the Raf-1/AP-1 signaling pathway
Fang Wang et al.
ONCOTARGET (2017)
Targeting endogenous proteins for degradation through the affinity-directed protein missile system
Luke J. Fulcher et al.
OPEN BIOLOGY (2017)
Therapeutic Antibodies against Intracellular Tumor Antigens
Iva Trenevska et al.
FRONTIERS IN IMMUNOLOGY (2017)
Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkers
Marilyne Labrie et al.
SCIENTIFIC REPORTS (2017)
Two birds, one stone: dual targeting of the cancer cell surface and subcellular mitochondria by the galectin-3-binding peptide G3-C12
Wei Sun et al.
ACTA PHARMACOLOGICA SINICA (2017)
Galectin-3 interacts with components of the nuclear ribonucleoprotein complex
Katharina Fritsch et al.
BMC CANCER (2016)
Metastatic Progression of Prostate Cancer Is Mediated by Autonomous Binding of Galectin-4-O-Glycan to Cancer Cells
Chin-Hsien Tsai et al.
CANCER RESEARCH (2016)
Galectin-3-Binding Glycomimetics that Strongly Reduce Bleomycin-Induced Lung Fibrosis and Modulate Intracellular Glycan Recognition
Tamara Delaine et al.
CHEMBIOCHEM (2016)
Active-site MMP-selective antibody inhibitors discovered from convex paratope synthetic libraries
Dong Hyun Nam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets
Andree-Anne Grosset et al.
ONCOTARGET (2016)
The role of galectin-4 in physiology and diseases
Zhan-Qi Cao et al.
PROTEIN & CELL (2016)
NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies
Sandrine Moutel et al.
ELIFE (2016)
A Mutation in the Carbohydrate Recognition Domain Drives a Phenotypic Switch in the Role of Galectin-7 in Prostate
Marilyne Labrie et al.
PLOS ONE (2015)
Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin
Maria Claudia Vladoiu et al.
ONCOTARGET (2015)
Galectin-4 serves as a prognostic biomarker for the early recurrence/metastasis of hepatocellular carcinoma
Zhixiong Cai et al.
CANCER SCIENCE (2014)
Galectin fingerprinting in naso-sinusal diseases
Anaelle Duray et al.
ONCOLOGY REPORTS (2014)
Nuclear transport of galectin-3 and its therapeutic implications
Tatsuyoshi Funasaka et al.
SEMINARS IN CANCER BIOLOGY (2014)
Inhibition of metastatic tumor formation in vivo by a bacteriophage display-derived galectin-3 targeting peptide
Jessica R. Newton-Northup et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Lactose binding to human galectin-7 (p53-induced gene 1) induces long-range effects through the protein resulting in increased dimer stability and evidence for positive cooperativity
Elena Ermakova et al.
GLYCOBIOLOGY (2013)
Galectin-4 Reduces Migration and Metastasis Formation of Pancreatic Cancer Cells
Ana I. Belo et al.
PLOS ONE (2013)
Galectin-4, a Novel Predictor for Lymph Node Metastasis in Lung Adenocarcinoma
Takuo Hayashi et al.
PLOS ONE (2013)
Treatment of prostate carcinoma with (Galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates
Yang Yang et al.
BIOMATERIALS (2012)
A distinctive role for galectin-7 in cancer ?
Yves St-Pierre et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2012)
Lowered expression of galectin-2 is associated with lymph node metastasis in gastric cancer
Ji-Han Jung et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Galectin-3 Regulates Intracellular Trafficking of EGFR through Alix and Promotes Keratinocyte Migration
Wei Liu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Antibody-enabled small-molecule drug discovery
Alastair D. G. Lawson
NATURE REVIEWS DRUG DISCOVERY (2012)
Galectin-4 functions as a tumor suppressor of human colorectal cancer
Arun Satelli et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Mitochondrial proteomic approach reveals galectin-7 as a novel BCL-2 binding protein in human cells
Christelle Villeneuve et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
Overexpression of Galectin-7, A Myoepithelial Cell Marker, Enhances Spontaneous Metastasis of Breast Cancer Cells
Melanie Demers et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Galectin-1 Is Implicated in the Protein Kinase C epsilon/Vimentin-Controlled Trafficking of Integrin-beta 1 in Glioblastoma Cells
Shannon Fortin et al.
BRAIN PATHOLOGY (2010)
Novel Fluorescent Glycan Microarray Strategy Reveals Ligands for Galectins
Xuezheng Song et al.
CHEMISTRY & BIOLOGY (2009)
Tid1 functions as a tumour suppressor in head and neck squamous cell carcinoma
Chi-Yuan Chen et al.
JOURNAL OF PATHOLOGY (2009)
Galectin-2 and -4, But Not Galectin-1, Promote Intestinal Epithelial Wound Healing In Vitro Through a TGE-beta-independent Mechanism
Daniela Paclik et al.
INFLAMMATORY BOWEL DISEASES (2008)
Intracellular localisation of galectin-3 has a protective role in chondrocyte survival
C. Boileau et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Galectin-7 in lymphoma:: Elevated expression in human lymphoid malignancies and decreased lymphoma dissemination by antisense strategies in experimental model
Melanie Demers et al.
CANCER RESEARCH (2007)
mTOR and cancer: insights into a complex relationship
David M. Sabatini
NATURE REVIEWS CANCER (2006)
Dual activities of galectin-3 in human prostate cancer:: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3
S Califice et al.
ONCOGENE (2004)
Galectin-3, a novel binding partner of β-catenin
T Shimura et al.
CANCER RESEARCH (2004)
Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity
G Elad-Sfadia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs
Y Takenaka et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations
LM Coussens et al.
SCIENCE (2002)
Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor
N Nagy et al.
GUT (2002)
Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation
A Paz et al.
ONCOGENE (2001)
Association of galectin-1 and galectin-3 with Gemin4 in complexes containing the SMN protein
JW Park et al.
NUCLEIC ACIDS RESEARCH (2001)
Share Paper
